Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


McKesson (MCK) Q4 2026 Earnings Transcript

2026-05-08
Brian Tyler: Thank you, Jeni. In our fiscal 2026, we grew adjusted earnings per diluted share by 18%, driven by momentum across our strategic growth platforms. At the beginning of the year, we added Core Ventures and PRISM Vision to our oncology and our multispecialty platforms.

Assessing McKesson (MCK) Valuation After Fiscal 2026 Earnings And Sector Volatility

2026-05-08
McKesson (MCK) is back in focus after reporting full year results for the period ended March 31, 2026, with sales of US$403.43b and net income of US$4.76b, along with higher earnings per share. See our latest analysis for McKesson. Despite the latest results, McKesson’s share price has had a weak patch recently. It delivered a 1-day share price return of 1.49% after a 30-day share price decline of 11.89% and a 90-day share price decline of 20.44%. However, the 5-year total shareholder return...

UBS Maintains Buy on McKesson, Raises Price Target to $1050

2026-05-08
UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $1000 to $1050.

MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up

2026-05-08
McKesson beats Q4 EPS estimates as oncology and specialty distribution growth offset revenue miss and lift segment margins.

JP Morgan Maintains Overweight on McKesson, Lowers Price Target to $1015

2026-05-08
JP Morgan analyst Lisa Gill maintains McKesson (NYSE:MCK) with a Overweight and lowers the price target from $1107 to $1015.

Nasdaq Tops 29,000 Records, Micron Soars 13%: Stock Market Today

2026-05-08
Nasdaq jumps 1.6% to record highs Friday as semiconductor rally and stronger-than-expected April payrolls overshadow ongoing Strait of Hormuz tensions.

Evercore ISI Group Maintains Outperform on McKesson, Lowers Price Target to $850

2026-05-08
Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and lowers the price target from $950 to $850.

Does McKesson's (MCK) Bigger Credit Line Quietly Redefine Its Capital Allocation Priorities?

2026-05-08
In the past quarter, McKesson Corporation reported fourth-quarter fiscal 2026 sales of US$96.30 billion and net income of US$1.68 billion, with full-year sales reaching US$403.43 billion and net income of US$4.76 billion, alongside a new US$5.00 billion multi-currency revolving credit facility maturing in 2031. The combination of higher earnings per share from continuing operations and expanded committed liquidity gives investors more information about McKesson’s capacity to fund operations,...

McKesson : Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K)

2026-05-08
Management's Discussion and Analysis of Financial Condition and Results of Operations. INDEX TO MANAGEMENT'S DISCUSSION AND ANALYSIS ...

Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics

2026-05-07
Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.